Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections work by slowing gastric emptying and signaling fullness to your brain, but correct placement matters for consistent drug delivery. Understanding where and how to inject ensures reliable dosing week to week. PlexusDx provides compounded semaglutide from licensed 503A pharmacies with complete injection training included in your treatment plan.
Approved Injection Sites for Semaglutide Therapy
Semaglutide is administered subcutaneously—meaning just under the skin—in three primary locations: the abdomen, upper arm, or thigh. Each site works equally well for drug absorption, though some patients experience slightly different comfort levels depending on body composition and injection anxiety. The abdomen offers the largest injection area and is often easiest for self-administration.
The upper arm, specifically the outer portion, provides good accessibility and is less visible for patients concerned about privacy. The front and outer thigh deliver consistent results and give patients flexibility if they prefer rotating between visible and non-visible sites. Clinical studies show absorption rates are comparable across all three approved zones when proper injection depth is maintained.
Why Rotating Your Injection Sites Matters
Rotating injection sites prevents lipohypertrophy, a buildup of fatty tissue at repeat injection spots that can slow medication absorption and lead to inconsistent blood glucose control. Patients who inject in the same exact location every week experience thickened, hardened skin that interferes with the drug reaching subcutaneous tissue effectively. Regular rotation maintains healthy skin and ensures your weekly dose works as intended throughout your treatment journey.
A practical rotation pattern involves using the abdomen for week one, the left thigh for week two, the right thigh for week three, and the upper arm for week four, then repeating the cycle. Within each body area, move the injection point at least one inch away from the previous site. This simple system prevents tissue damage while keeping your administration simple and trackable.
Proper Injection Depth and Technique
Subcutaneous injections require the needle to penetrate approximately one-quarter to one-half inch below the skin surface—deep enough to reach fatty tissue but shallow enough to avoid muscle. Using the correct needle gauge (typically 28–30 gauge for semaglutide) ensures the injection goes to the right depth without causing unnecessary discomfort or bruising. PlexusDx provides detailed video tutorials and written guides with your first shipment to ensure you master proper technique from day one.
Before injecting, pinch the skin gently to lift it away from muscle, then insert the needle at a 45- to 90-degree angle depending on your body composition. Hold the needle steady for three to five seconds after full depression to allow the medication to disperse into surrounding tissue. Slow, controlled injection reduces discomfort and ensures even drug distribution across the injection site.
Managing Pain, Bruising, and Common Side Effects at Injection Sites
Mild bruising, redness, or soreness at the injection site affects roughly 10–15% of semaglutide users and typically resolves within 24–48 hours. Applying a cold compress before injection numbs the area and reduces post-injection inflammation. Taking the needle out slowly and applying gentle pressure with a cotton ball for 10 seconds minimizes bleeding and bruising risk.
If you experience persistent pain, swelling lasting more than three days, or signs of infection such as warmth or pus, contact your PlexusDx provider immediately. Most injection-site discomfort decreases significantly after the first two to three weeks as your body acclimates to the medication schedule. Ensuring needles are sharp, never reused, and stored at room temperature also reduces tissue trauma and patient-reported pain levels.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into the same spot every week?
No—injecting the same spot repeatedly causes lipohypertrophy, a fatty tissue buildup that slows medication absorption and reduces treatment effectiveness. Rotate your injection site systematically across your abdomen, thighs, and upper arm to maintain healthy skin and consistent dosing. PlexusDx provides a rotation chart with your first order to simplify the process.
What does clinical evidence say about absorption rates across different injection sites?
Multiple randomized trials confirm that subcutaneous semaglutide shows comparable pharmacokinetics whether injected into the abdomen, thigh, or upper arm. Absorption timing and peak drug levels remain consistent across all three approved sites, so your choice can be based on comfort and convenience. Site rotation is recommended purely to prevent tissue remodeling, not to optimize absorption.
How much does PlexusDx semaglutide cost per month?
PlexusDx compounded semaglutide injection starts at $149 per month across all dose levels—your dose may need to go up, but your price won't. The medication is HSA/FSA eligible, requires no insurance, and includes access to injection training videos and provider support. All medications come from licensed 503A compounding pharmacies.
Is bruising or soreness at the injection site normal and dangerous?
Mild bruising and soreness are common and typically harmless, resolving within one to two days. Using a cold compress before injection, rotating sites, and ensuring proper needle depth and speed minimize discomfort. Contact your PlexusDx provider if bruising persists beyond three days or if you notice signs of infection such as increasing warmth or drainage.
How does the PlexusDx Precision Peptide Genetic Test inform injection decisions?
While the Precision Peptide Genetic Test ($99 add-on) identifies genetic variants affecting GLP-1 receptor sensitivity and peptide metabolism, injection site selection and rotation are the same for all patients regardless of genetic profile. However, your test results may help your PlexusDx provider optimize your starting dose and predict how quickly you might need dose escalation, improving your overall treatment timeline and outcomes.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Zepbound: How Many Units is 2.5 mg of Zepbound?
Is Wegovy a Shot or a Pill? Choosing Your Best Path to Sustainable Weight Loss